Evidence map›Paper›PMID 33020179›Full record

ArticleThe Journal of biological chemistry2020

Microtubule affinity-regulating kinase 4 with an Alzheimer's disease-related mutation promotes tau accumulation and exacerbates neurodegeneration.

Toshiya Oba, Taro Saito, Akiko Asada, Sawako Shimizu, Koichi M Iijima, Kanae Ando

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Mirtazapine revisited: new therapeutic perspectives and formulation advances.Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Tauopathy in AD: Therapeutic Potential of MARK-4.Current Alzheimer research · 2024
    Review
  14. Brain communications · 2024
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Toshiya ObaGraduate School of Science, Tokyo Metropolitan University, Tokyo, Japan.
Taro SaitoGraduate School of Science, Tokyo Metropolitan University, Tokyo, Japan; Department of Biological Sciences, School of Science, Tokyo Metropolitan University, Tokyo, Japan.
Akiko AsadaGraduate School of Science, Tokyo Metropolitan University, Tokyo, Japan; Department of Biological Sciences, School of Science, Tokyo Metropolitan University, Tokyo, Japan.
Sawako ShimizuGraduate School of Science, Tokyo Metropolitan University, Tokyo, Japan.
Koichi M IijimaDepartment of Alzheimer's Disease Research, National Center for Geriatrics and Gerontology, Obu, Japan; Department of Experimental Gerontology, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan.
Kanae AndoGraduate School of Science, Tokyo Metropolitan University, Tokyo, Japan; Department of Biological Sciences, School of Science, Tokyo Metropolitan University, Tokyo, Japan. Electronic address: k_ando@tmu.ac.jp.
Tokyo Metropolitan University · JPNagoya City University · JP

Funding

Drosophila Transgenic RNAi Resource ProjectR01GM084947 · NIGMS · HARVARD MEDICAL SCHOOL · PI PERRIMON, NORBERT · 2008 to 2019
$9.8M
NIGMS NIH HHS R01 GM084947
6 · The paper itself

Abstract

Accumulation of the microtubule-associated protein tau is associated with Alzheimer's disease (AD). In AD brain, tau is abnormally phosphorylated at many sites, and phosphorylation at Ser-262 and Ser-356 plays critical roles in tau accumulation and toxicity. Microtubule affinity-regulating kinase 4 (MARK4) phosphorylates tau at those sites, and a double

Indexed as

Gain of Function MutationProtein MultimerizationAlzheimer DiseaseAnimalsAnimals, Genetically ModifiedDrosophila melanogasterDrosophila ProteinsHEK293 CellsHumansProtein Serine-Threonine Kinasestau ProteinsDrosophila ProteinsMARK4 protein, humanProtein Serine-Threonine Kinasestau ProteinsAlzheimer's disease (AD)Drosophilamicrotubule affinity–regulating kinase 4 (MARK4)neurodegenerationphosphorylationtau protein (tau)

Identifiers

PMID33020179
PMCPMC7863894
OpenAlexW3091491136

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.